From data to drugs: How AI is revolutionising drug development

The laboratory at Terray Therapeutics is a symphony of miniaturised automation. Robots whir, shuttling tiny tubes of fluids to their stations. Scientists in blue coats, sterile gloves and protective glasses monitor the machines.

But the real action is happening at the nanoscale. Proteins in solution combine with chemical molecules held in minuscule wells in custom silicon chips that are like microscopic muffin tins.